← Back to Search

Dietary Supplement

Calcium Supplements for Kidney Stones Prevention in Crohn's Disease

N/A
Recruiting
Led By Ben Chew, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pathologically confirmed diagnosis of Crohn's disease
Prior ileal resection with an intact colon (surgery > 6 months preceding involvement in study)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial is studying how well calcium works in reducing oxalate in urine of people with inflammatory bowel disease.

Eligible Conditions
  • Kidney Stones
  • Crohn's Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with Crohn's disease by a doctor using specific tests.
Select...
You had surgery to remove part of your small intestine with the colon left intact more than 6 months ago.
Select...
You will not be excluded from the study if you have a history of kidney stones.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Molar ratio of urinary calcium:oxalate in relation to the supersaturation product of calcium oxalate
Secondary outcome measures
Optimal level of Ca supplementation for prevention of stones in Crohn's patients

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dietary supplementExperimental Treatment1 Intervention
Calcium Carbonate
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Calcium Carbonate
2011
Completed Phase 4
~7280

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,509 Total Patients Enrolled
12 Trials studying Kidney Stones
4,642 Patients Enrolled for Kidney Stones
University of Texas Southwestern Medical CenterOTHER
1,038 Previous Clinical Trials
1,046,731 Total Patients Enrolled
3 Trials studying Kidney Stones
532 Patients Enrolled for Kidney Stones
Ben Chew, MDPrincipal InvestigatorUniversity of British Columbia
9 Previous Clinical Trials
964 Total Patients Enrolled
4 Trials studying Kidney Stones
753 Patients Enrolled for Kidney Stones

Media Library

Calcium Carbonate (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT01735461 — N/A
Kidney Stones Research Study Groups: Dietary supplement
Kidney Stones Clinical Trial 2023: Calcium Carbonate Highlights & Side Effects. Trial Name: NCT01735461 — N/A
Calcium Carbonate (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01735461 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are contributing to this medical experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this healthcare study, first posted on December 1st 2012, is actively recruiting patients. Forty participants must be enrolled from a single site."

Answered by AI

Is this clinical trial currently enrolling participants?

"This medical trial, which was originally listed on December 1st 2012, is currently seeking participants. The information has been updated most recently as of May 16th 2022 according to clinicaltrials.gov."

Answered by AI

Who else is applying?

What site did they apply to?
Vancouver General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby Mar 2025